{
    "nctId": "NCT06272864",
    "briefTitle": "BostonGene and Exigent Genomic INsight Study",
    "officialTitle": "BostonGene and Exigent Genomic INsight (BEGIN) Study: A Prospective Study of Comprehensive Molecular Testing in Advanced Cancer Patients in the Community Setting",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Cancer, Non-small Cell Lung Cancer, Melanoma, Sarcoma",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 400,
    "primaryOutcomeMeasure": "Frequency of actionable findings",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Patients must have a confirmed malignancy of:\n\nLocally recurrent, unresectable, or metastatic breast cancer or; Unresectable stage III or metastatic non-small cell lung cancer or; Unresectable or metastatic melanoma or; Locally advanced or metastatic l sarcoma.\n\n* Life expectancy \\> 3 months as per the treating physician\n* Willingness to provide informed consent\n* Living in the United States at time of enrollment\n* Agree to participate in genomic and molecular profiling\n\nExclusion Criteria:\n\n* not meeting the inclusion criteria",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}